首页|解毒舒肝活血方对原发性肝癌微波消融术后的疗效及对患者肿瘤标志物、免疫功能的影响

解毒舒肝活血方对原发性肝癌微波消融术后的疗效及对患者肿瘤标志物、免疫功能的影响

扫码查看
目的:评价原发性肝癌(PLC)患者微波消融术后应用解毒舒肝活血方治疗的疗效,观察患者肿瘤标志物及免疫相关指标变化.方法:选择我院2021年1月~2023年12月的120例微波消融术的原发性肝癌患者作为研究对象,采用随机数字表法分为两组,对照组60例术后给予常规保肝降酶、抗病毒等治疗,观察组60例在此基础上给予解毒舒肝活血方治疗,比较两组疗效及治疗前、后血清甲胎蛋白(AFP)、甲胎蛋白异质体L3(AFP-L3)、CD3+、CD4+、CD8+细胞绝对值及CD4+/CD8+比值.结果:观察组ORR、DCR分别为65.00%、91.67%,均高于对照组的41.67%、81.67%(P<0.05).治疗后两组AFP、AFP-L3水平均低于治疗前(P<0.05).观察组治疗后AFP、AFP-L3水平均低于对照组(P<0.05).治疗后观察组CD3+、CD4+细胞绝对值及CD4+/CD8+比值均高于治疗前,CD8+绝对值低于治疗前(P<0.05).观察组治疗后CD3+、CD4+细胞绝对值及CD4+/CD8+比值均高于对照组,CD8+绝对值低于对照组(P<0.05).结论:解毒舒肝活血方可在一定程度上改善PLC患者微波消融术后的细胞免疫功能,降低肿瘤标志物水平,提高近期疗效.
The efficacy of Jiedu Shugan Huoxue recipe for primary liver cancer after microwave ablation and its effect on tumor markers and immune function of patients
Objective:To evaluate the efficacy of Jiedu Shugan Huoxue Decoction in the treatment of patients with primary liver cancer(PLC)after microwave ablation,and observe the changes of tumor markers and immune-related indicators.Meth-ods:A total of 120patients with PLC who underwent microwave ablation in our hospital from January 2021 to December 2023were selected as the research objects,and were divided into two groups according to the random number table method.The control group(60cases)was given conventional treatment such as liver protection,enzymatic reduction and antiviral treatment after oper-ation,and the observation group(60cases)was given Jiedu Shugan Huoxue Decoction on this basis.The efficacy of the two groups and the serum alpha fetoprotein(AFP),alpha fetoprotein L3(AFP-L3),CD3+,CD4+,CD8+cell absolute value and CD4+/CD8+ratio before and after treatment were compared.Results:ORR and DCR in observation group were 65.00%and 91.67%,respectively,which were higher than 41.67%and 81.67%in control group(P<0.05).After treatment,the levels of AFP and AFP-L3were lower than before treatment(P<0.05).After treatment,the levels of AFP and AFP-L3in observation group were lower than those in control group(P<0.05).After treatment,the absolute values of CD3+,CD4+cells and CD4+/CD8+ratio in observation group were higher than before treatment,and the absolute values of CD8+were lower than before treat-ment(P<0.05).After treatment,the absolute values of CD3+,CD4+and CD4+/CD8+ratio in observation group were higher than those in control group,and the absolute values of CD8+were lower than those in control group(P<0.05).Conclusion:The prescription of detoxifying and soothing liver and activating blood can improve the cellular immune function,reduce the levels of tumor markers and improve the short-term efficacy of PLC patients after microwave ablation to a certain extent.

Primary liver cancerMicrowave ablationdetoxifying and soothing liver and activating blood prescriptiontumor markersimmune function

许淑君、刘凤新、韩钰、陈俊洁、李月、宫富琪、刘杰生、孙韬

展开 >

沧州市第三医院中西医结合肝病科,河北沧州 061000

沧州市第三医院医务科,河北沧州 061000

原发性肝癌 微波消融术 解毒舒肝活血方 肿瘤标志物 免疫功能

河北省中医药管理局科研项目

2024501

2024

四川中医
四川省中医药学会,四川省中西医结合学会,四川省针灸学会,四川省中医药科学院

四川中医

CSTPCD
影响因子:0.522
ISSN:1000-3649
年,卷(期):2024.42(5)
  • 15